Monoclonal antibody treatment in rheumatoid arthritis: The clinical and immunological effects of a CD7 monoclonal antibody

Rheumatology

Volumn 30, Issue 6, 1991, Pages 459-463

  Kirkham, B W ^a   Pitzalis, C ^a   Kingsley, G H ^a   Chikanza, I C ^a   Sabharwal, S ^a   Barbatis, C ^a,b   Grahame, R ^a   Gibson, T ^a   Amlot, P L ^a,c   Panayi, G S ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Antigen modulation; Immunotherapy; RA

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FEVER; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LOW BACK PAIN; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; VASCULITIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD7; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ARTHRITIS, RHEUMATOID; FEMALE; HUMAN; IMMUNOSUPPRESSION; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; SYNOVIAL MEMBRANE; T-LYMPHOCYTE SUBSETS;

EID: 0026410278     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/30.6.459     Document Type: Article

References (30)

1. Janossy G, Panayi GS, Duke O, Bofill M, Poulter LW, Goldstein G. Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet 1981;ii:839-42.
2. Duke O, Panayi GS, Janossy G, Poulter LW. An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin Exp Immunol 1982;49:22-30.
3. Klareskog L, Forsum U, Wigren A, Wigzell H. Relationships between HLA-DR-expressing cells and T-lymphocytes of different subsets in rheumatoid synovial tissue. Scand J Immunol 1981; 15:501-7.
4. Paulus HE, Machleder MI, Levine S, Yu DT, Mac- Donald NS. Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum 1977;20:1249-62.
5. Emery P, Smith GN, Panayi GS. Lymphocytaphoresis— a feasible treatment of rheumatoid arthritis. Br J Rheumatol 1986;25:40-3.
6. Sherrer Y, Bloch D, Strober S, Fries J. Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis. J Rheumatol 1987;14:46-51.
7. Schluesener H, Brunner C, Vass K, Lassman H. Therapy of rat autoimmune disease by a monoclonal antibody specific for T-lymphoblasts. J Immunol 1986;137:3814-20.
8. 4J Immunol 1987; 138:3247-53.
9. 4J Exp Med 1985;162:1105-10.
10. Larsson P, Holmdahl R, Dencker L, Klareskog L. In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. Immunology 1985;56:383-91.
11. Horn JT, Butler LD, Riedl PE, Bendele AM. The progression of the inflammation in established collagen- induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T-cell activities. Eur J Immunol 1988;18:881-8.
12. Banerjee S, Wei B-Y, Hillman K, Luthrra HS, David CS. Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody. J Immunol 1988;141:1150-4.
13. van Lambalgen R, Jonker M. Experimental allergic encephalomyelitis in rhesus monkeys: II. Treatment of EAE with anti-T-lymphocyte subset monoclonal antibodies. Clin Exp Immunol 1987;67: 305-12.
14. Jonker M. Immunosuppressive therapy by monoclonal anti-T-lymphocyte subset monoclonal antibodies. In: McMichael AJ, ed. Leucocyte typing III. Oxford: Oxford University Press, 1987:923-7.
15. Vigeral P, Chkoff N, Chatenoud L, et al. Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent. Transplantation 1986; 41:730-3.
16. Ortho Multicentre Transplant Study Group. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985;313:337–42.
17. Herzog C, Walker C, Pichler W, et al. Monoclonal anti-CD4 in arthritis. Lancet 1987;ii:1461-2.
18. Kyle V, Coughlan RJ, Tighe H, Waldmann H, Hazelman BL. Beneficial effect of monoclonal antibody to interleukin-2 receptor on activated T-cells in rheumatoid arthritis. Ann Rheum Dis 1989;48: 428-9.
19. Raftery MJ, Lang CJ, Ivory K, et al. Use of RFT2 (CD7) monoclonal antibody as prophylaxis against renal allograft rejection. Transplant Proc 1985;17: 2737-9.
20. Lazarovits Al, Colvin RB, Camerini D, Karsh J, Kurnick JT. Modulation of CD7 is associated with T-lymphocyte function. In: Michael AJ, ed. Leucocyte typing 111. Oxford: Oxford University Press, 1987;219-23.
21. Poulter LW, Duke O, Panayi GS, Hobbs S, Raftery MJ, Janossy G. Activated T-lymphocytes of the synovial membrane in rheumatoid arthritis and other arthropathies. Scand J Immunol 1985;22:683-90.
22. Lazarovits Al, Karsh J. Decreased expression of CD7 occurs in rheumatoid arthritis. Clin Exp Immunol 1988;72:470-5.
23. Tax WJM, Tidman N, Janossy GJ, et al. Monoclonal antibody (WT1) directed against a T-cell surface glycoprotein. Characteristics and immunosuppressive activity. Clin Exp Immunol 1984;55:427-36.
24. Ropes MW, Bennet GA, Cobb S, Jacox R, Jesser RA. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-6.
25. Ritchie DM, Boyle JA, Mclnnes JM, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:393–406.
26. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. ScandJ Clin Lab Invest 1968;21 (Suppl 97):77.
27. Kirkham BW, Pitzalis C, Kingsley GH, Timms AM, Kyriazis N, Panayi GS. Rheumatoid T-lymphocyte MHC class II expression: in vitro stimulation produces normal MHC class II expression, independent of proliferation. J Rheumatol 1989; 16:270-5.
28. Hsu SM, Raine L, Fanger H. Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
29. Kummer U, Thierfelder S, Hoffman-Fezer G, Schuh R. In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their Clq uptake. J Immunol 1987;138:4069-74.
30. Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy. Nature 1988;332:323-5.